Brad Hively - 03 Jun 2025 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Director
Signature
/s/ Mark Hueppelsheuser, Attorney-in-Fact for Brad Hively
Issuer symbol
TOI
Transactions as of
03 Jun 2025
Transactions value $
-$3,989,582
Form type
4
Filing time
05 Jun 2025, 18:51:15 UTC
Previous filing
28 Apr 2025
Next filing
21 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hively Brad Director C/O THE ONCOLOGY INSTITUTE INC., 18000 STUDEBAKER ROAD, SUITE 800, CERRITOS /s/ Mark Hueppelsheuser, Attorney-in-Fact for Brad Hively 05 Jun 2025 0001891124

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common Stock Options Exercise $582K +685K +96.14% $0.85 1.4M 03 Jun 2025 Direct
transaction TOI Common Stock Options Exercise $50.7K +105K +7.54% $0.48 1.5M 03 Jun 2025 Direct
transaction TOI Common Stock Options Exercise $246K +131K +8.74% $1.87 1.63M 03 Jun 2025 Direct
transaction TOI Common Stock Options Exercise $804K +946K +57.95% $0.85 2.58M 03 Jun 2025 Direct
transaction TOI Common Stock Sale -$5.36M -1.87M -72.4% $2.87 712K 03 Jun 2025 Direct
transaction TOI Common Stock Sale -$312K -109K -15.24% $2.87 604K 03 Jun 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TOI Non-Qualified Stock Option (right to buy) Options Exercise $0 +685K $0.00 0 03 Jun 2025 Common Stock 685K $0.85 Direct F2, F6
transaction TOI Non-Qualified Stock Option (right to buy) Options Exercise $0 +105K $0.00 0 03 Jun 2025 Common Stock 105K $0.48 Direct F3, F6
transaction TOI Non-Qualified Stock Option (right to buy) Options Exercise $0 +131K $0.00 0 03 Jun 2025 Common Stock 131K $1.87 Direct F4, F6
transaction TOI Non-Qualified Stock Option (right to buy) Options Exercise $0 +946K $0.00 0 03 Jun 2025 Common Stock 946K $0.85 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents sale of Common Stock acquired from previously vested RSU awards.
F2 These options vested monthly for 36 months following November 12, 2021.
F3 These options vested monthly starting March 17, 2023, with cancellation of remaining options pursuant to Note 6 below.
F4 These options vested monthly starting November 17, 2022, with cancellation of remaining options pursuant to Note 6 below.
F5 These options vested monthly for 48 months following December 2, 2019.
F6 Pursuant to a Transition Agreement with the Reporting Person, all unvested options were cancelled after June 30, 2024.